Published in PLoS One on September 03, 2013
Developmental cigarette smoke exposure II: Kidney proteome profile alterations in 6 month old adult offspring. Reprod Toxicol (2016) 0.76
Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity. Am J Nephrol (2016) 0.76
Infant exposure to Chinese famine increased the risk of hypertension in adulthood: results from the China Health and Retirement Longitudinal Study. BMC Public Health (2016) 0.75
Complications during pregnancy and fetal development: implications for the occurrence of chronic kidney disease. Expert Rev Cardiovasc Ther (2017) 0.75
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature (1996) 4.37
Renal and neuronal abnormalities in mice lacking GDNF. Nature (1996) 4.06
Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (1996) 3.82
Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation. Am J Transplant (2006) 2.40
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem (2005) 2.05
Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int (2004) 2.00
Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol (2011) 1.79
Posttranslational protein modifications, with special attention to collagen and elastin. Physiol Rev (1975) 1.69
A study of renal outcomes in obese living kidney donors. Transplantation (2010) 1.67
Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int (2004) 1.65
Adverse renal consequences of obesity. Am J Physiol Renal Physiol (2008) 1.62
Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol (2008) 1.47
Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension (1993) 1.43
Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int (2000) 1.43
Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol (2005) 1.40
Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension (2003) 1.37
Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am J Pathol (2011) 1.37
The effect of relaxin on collagen metabolism in the nonpregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity. Endocrinology (1996) 1.17
Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens (2000) 1.16
Nephron endowment in glial cell line-derived neurotrophic factor (GDNF) heterozygous mice. Kidney Int (2001) 1.08
Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int (2005) 1.07
Hypertension after neonatal uninephrectomy in rats precedes glomerular damage. Hypertension (2001) 1.06
Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors. Am J Transplant (2008) 1.06
Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol (2009) 1.04
Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant (2009) 1.03
Mechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci (1999) 1.01
Differential effects of diet-induced obesity on BKCa {beta}1-subunit expression and function in rat skeletal muscle arterioles and small cerebral arteries. Am J Physiol Heart Circ Physiol (2011) 0.99
Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney. Curr Opin Nephrol Hypertens (2010) 0.99
Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol (2011) 0.94
Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy. Nephrol Dial Transplant (2005) 0.91
High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment. Am J Physiol Renal Physiol (2010) 0.91
High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats. Hypertension (2005) 0.87
Reflex release of vasopressin and renin in hemorrhage is enhanced by autonomic blockade. Am J Physiol (1990) 0.86
Early glomerular alterations in genetically determined low nephron number. Am J Physiol Renal Physiol (2010) 0.83
High nephron endowment protects against salt-induced hypertension. Am J Physiol Renal Physiol (2012) 0.82
Exercise training in obesity lowers blood pressure independent of weight change. Med Sci Sports Exerc (2002) 0.80
Renal functional reserve compared in haemolytic uraemic syndrome and single kidney. Arch Dis Child (1990) 0.80
Glomerular surface area is normalized in mice born with a nephron deficit: no role for AT1 receptors. Am J Physiol Renal Physiol (2008) 0.78
Run kidney, run: lifestyle interventions in the prevention of kidney disease. J Hypertens (2011) 0.76
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int (2011) 3.96
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
Reactive oxygen species enhance insulin sensitivity. Cell Metab (2009) 2.77
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res (2003) 2.69
Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care (2011) 2.27
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes (2010) 1.95
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol (2005) 1.95
Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology (2008) 1.91
Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab (2008) 1.90
Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol (2006) 1.88
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol (2009) 1.86
Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol (2011) 1.82
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ Res (2012) 1.78
Management of Dieulafoy's lesion in the endoscopic era. J Clin Gastroenterol (2003) 1.73
Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J (2006) 1.73
Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care (2006) 1.70
Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol (2006) 1.70
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes (2004) 1.67
Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int (2011) 1.63
Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol (2007) 1.61
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int (2010) 1.57
Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem (2001) 1.57
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes (2004) 1.51
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation. Clin Sci (Lond) (2012) 1.49
Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes (2010) 1.48
Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease. Hypertension (2014) 1.45
Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse. Hypertension (2012) 1.43
Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol (2005) 1.40
The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells (2006) 1.40
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes (2012) 1.38
Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension (2003) 1.37
Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am J Pathol (2011) 1.37
ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes (2008) 1.36
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes (2002) 1.36
Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol (2011) 1.36
Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring. J Physiol (2007) 1.34
The buried bumper syndrome: a simple management approach in two patients. Gastrointest Endosc (2002) 1.34
Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am J Pathol (2010) 1.33
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J (2003) 1.33
Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol (2003) 1.32
Renal cilia display length alterations following tubular injury and are present early in epithelial repair. Nephrol Dial Transplant (2007) 1.28
Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab (2005) 1.26
Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol (2009) 1.26
Renal primary cilia lengthen after acute tubular necrosis. J Am Soc Nephrol (2009) 1.23
Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension (2005) 1.22
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy. Diabetes (2011) 1.22
Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am J Respir Cell Mol Biol (2007) 1.19
Nutrient sensing, autophagy, and diabetic nephropathy. Diabetes (2012) 1.19
Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res (2003) 1.16
The directed differentiation of human iPS cells into kidney podocytes. PLoS One (2012) 1.15
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. J Am Soc Nephrol (2004) 1.15
Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptor. Hypertension (2010) 1.14
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens (2010) 1.12
PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant (2006) 1.11
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2. FASEB J (2008) 1.09
Augmented and accelerated nephrogenesis in TGF-beta2 heterozygous mutant mice. Pediatr Res (2008) 1.09
Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl₄-treated mice. Cell Transplant (2010) 1.07
The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Rev Mol Med (2010) 1.07
Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm (2012) 1.04
Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes. Clin Sci (Lond) (2008) 1.04
A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat (2005) 1.04
The "his and hers" of the renin-angiotensin system. Curr Hypertens Rep (2013) 1.03
Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow. Am J Physiol Renal Physiol (2005) 1.03
Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry (2006) 1.03
Diastolic dysfunction is associated with anaemia in patients with Type II diabetes. Clin Sci (Lond) (2006) 1.02
Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells Dev (2010) 1.02
The regulation of fibrosis in airway remodeling in asthma. Mol Cell Endocrinol (2012) 1.02
Role of NOX2 in the regulation of afferent arteriole responsiveness. Am J Physiol Regul Integr Comp Physiol (2008) 1.01
Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS. PLoS One (2012) 1.01
Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens (2012) 1.01
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. Stem Cell Res (2011) 1.00
Alterations in renal cilium length during transient complete ureteral obstruction in the mouse. J Anat (2008) 0.99
Mesenchymal stem cells in kidney inflammation and repair. Nephrology (Carlton) (2012) 0.98
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Nephrol Dial Transplant (2002) 0.96
Relaxin modulates fibroblast function, collagen production, and matrix metalloproteinase-2 expression by cardiac fibroblasts. Ann N Y Acad Sci (2005) 0.96
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol (2009) 0.96
Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis. Endocrinology (2010) 0.96
Macrophages in renal development, injury, and repair. Semin Nephrol (2010) 0.95
Targets to retard the progression of diabetic nephropathy. Kidney Int (2005) 0.95
Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes (2010) 0.94
Is there an association between level of adult blood pressure and nephron number or renal filtration surface area? Kidney Int (2004) 0.94
M2 macrophage polarisation is associated with alveolar formation during postnatal lung development. Respir Res (2013) 0.93
Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension (2012) 0.93
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice. Diabetes (2012) 0.93
Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am J Pathol (2011) 0.93
Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. J Pharmacol Exp Ther (2010) 0.92
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. Am J Physiol Renal Physiol (2010) 0.92
Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab (2008) 0.92
Relaxin: new peptides, receptors and novel actions. Trends Endocrinol Metab (2003) 0.92
Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS One (2013) 0.92
Blockade of p38 mitogen-activated protein kinase and TGF-beta1/Smad signaling pathways rescues bone marrow-derived peritubular capillary endothelial cells in adriamycin-induced nephrosis. J Am Soc Nephrol (2006) 0.91
High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment. Am J Physiol Renal Physiol (2010) 0.91
Neuronal nitric oxide synthase-deficient mice have impaired renin release but normal blood pressure. Am J Hypertens (2008) 0.91
Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Endocrinology (2007) 0.91